A case of aggressive systemic mastocytosis with bulky lymphadenopathy showing response to midostaurin

被引：1
|
作者：
Sciume, Mariarita [1 ]
Serpenti, Fabio [2 ]
Muratori, Simona [3 ]
Pravettoni, Valerio [4 ]
Ulivieri, Fabio Massimo [5 ]
Croci, Giorgio Alberto [6 ]
Migliorini, Anna Chiara [7 ]
Esposito, Andrea [8 ]
Goldaniga, Maria Cecilia [1 ]
Saporiti, Giorgia Natascia [1 ]
Galassi, Giulia [1 ]
Baldini, Luca [1 ,2 ]
Onida, Francesco [1 ,2 ]
Grifoni, Federica Irene [1 ]
机构：
[1] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Hematol Unit, Milan, Italy
[2] Univ Milan, Milan, Italy
[3] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Physiopathol & Transplantat, Dermatol Unit, Milan, Italy
[4] Fdn IRCCS Ca Granda Osped Maggiore Policlin, UOC Gen Med Immunol & Allergol, Milan, Italy
[5] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Bone Metab Unit, Nucl Med, Milan, Italy
[6] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Pathophysiol & Transplantat, Div Pathol, Milan, Italy
[7] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Serv Immunoematol & Trasfus, Lab Ematol, Milan, Italy
[8] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Div Radiol, Milan, Italy
来源：
CLINICAL CASE REPORTS | 2021年 / 9卷 / 02期
关键词：
bulky lymphadenopathy; midostaurin; purine analogue; systemic mastocytosis; ADULTS; NEOPLASMS; EFFICACY; SAFETY;
D O I：
10.1002/ccr3.3717
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Management of systemic mastocytosis is an emerging challenge which requires a multidisciplinary diagnostic approach and personalized treatment strategy. Midostaurin can rapidly reduce the disease burden, also in cladribine refractory cases.
引用
收藏
页码：978 / 982
页数：5
相关论文
共 50 条
  • [21] Therapeutic management and outcome of patients with advanced systemic mastocytosis treated with midostaurin: A comprehensive real-life study in the French national healthcare database
    Rossignol, Julien
    Nizard, Sandra
    Blanc, Anne-Sandrine
    Filipovics, Anne
    Lortet-Tieulent, Joannie
    Bouktit, Hassiba
    Poinsot, Gwendoline
    Schmidt, Aurelie
    Raguideau, Fanny
    Hermine, Olivier
    HEMATOLOGICAL ONCOLOGY, 2022, 40 (05) : 1030 - 1040
  • [22] Aggressive Systemic Mastocytosis Associated with Mesangioproliferative Glomerulonephritis
    Diamantidis, Michael D.
    Myrou, Athena D.
    Kaiafa, Georgia D.
    Kaloutsi, Vasiliki
    Karayannopoulou, Georgia
    Theodoridis, Andreas
    Adamidou, Alexandra
    Papadopoulos, Athanasios
    Grekas, Dimitrios
    ACTA HAEMATOLOGICA, 2011, 125 (03) : 153 - 159
  • [23] Response and progression on midostaurin in advanced systemic mastocytosis: KIT D816V and other molecular markers
    Jawhar, Mohamad
    Schwaab, Juliana
    Naumann, Nicole
    Horny, Hans-Peter
    Sotlar, Karl
    Haferlach, Torsten
    Metzgeroth, Georgia
    Fabarius, Alice
    Valent, Peter
    Hofmann, Wolf-Karsten
    Cross, Nicholas C. P.
    Meggendorfer, Manja
    Reiter, Andreas
    BLOOD, 2017, 130 (02) : 137 - 145
  • [24] Response and resistance to cladribine in patients with advanced systemic mastocytosis: a registry-based analysis
    Luebke, Johannes
    Naumann, Nicole
    Metzgeroth, Georgia
    Kreil, Sebastian
    Brand, Timo
    Horny, Hans-Peter
    Sotlar, Karl
    Cross, Nicholas C. P.
    Fabarius, Alice
    Valent, Peter
    Hofmann, Wolf-Karsten
    Reiter, Andreas
    Schwaab, Juliana
    ANNALS OF HEMATOLOGY, 2023, 102 (08) : 2077 - 2085
  • [25] An Unusual Case of Aggressive Systemic Mastocytosis With Associated Refractory Plasma Cell Myeloma
    Jain, Preetesh
    Verstovsek, Srdan
    Orlowski, Robert Z.
    Yap, Ernie
    Amin, Hesham M.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2012, 12 (06) : 459 - 462
  • [26] Practical management of adverse events in patients with advanced systemic mastocytosis receiving midostaurin
    Gotlib, Jason
    Kluin-Nelemans, Hanneke C.
    Akin, Cem
    Hartmann, Karin
    Valent, Peter
    Reiter, Andreas
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (04) : 487 - 498
  • [27] Response Criteria in Advanced Systemic Mastocytosis: Evolution in the Era of KIT Inhibitors
    Shomali, William
    Gotlib, Jason
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (06) : 1 - 16
  • [28] Midostaurin: a novel therapeutic agent for patients with FLT3-mutated acute myeloid leukemia and systemic mastocytosis
    Gallogly, Molly M.
    Lazarus, Hillard M.
    Cooper, Brenda W.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2017, 8 (09) : 245 - 261
  • [29] Systemic Mastocytosis: Case Report with Literature Review
    Mitrovic, Mirjana
    Perunicic-Jovanovic, Maja
    Sokic-Milutinovic, Aleksandra
    Andrejevic, Sladjana
    Suvajdzic, Nada
    SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2012, 140 (1-2) : 100 - 103
  • [30] Superior Efficacy of Midostaurin Over Cladribine in Advanced Systemic Mastocytosis: A Registry-Based Analysis
    Luebke, Johannes
    Schwaab, Juliana
    Naumann, Nicole
    Horny, Hans-Peter
    Weiss, Christel
    Metzgeroth, Georgia
    Kreil, Sebastian
    Cross, Nicholas C. P.
    Sotlar, Karl
    Fabarius, Alice
    Hofmann, Wolf-Karsten
    Valent, Peter
    Gotlib, Jason
    Jawhar, Mohamad
    Reiter, Andreas
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : 1783 - +
12345